Erythropoietin API Manufacturer & Supplier in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Erythropoietin API Manufacturer & Supplier in India

Erythropoietin (EPO) is a naturally occurring glycoprotein hormone that plays a central role in the regulation of red blood cell production. It stimulates the proliferation and differentiation of erythroid progenitor cells in the bone marrow and helps maintain physiological red blood cell mass.

Recombinant human erythropoietin is manufactured using recombinant DNA technology and is used as an erythropoiesis-stimulating agent (ESA) in pharmaceutical products. Recombinant epoetin alfa contains 165 amino acids and has an approximate molecular weight of 30,400 daltons.

What is Erythropoietin?

Erythropoietin is a glycosylated protein hormone produced primarily by the kidneys in response to reduced oxygen availability. It binds to the erythropoietin receptor (EPOR) on erythroid precursor cells and activates signaling pathways involved in erythroid-cell survival, proliferation and differentiation.

Recombinant forms such as epoetin alfa and epoetin beta are produced through cell-culture and recombinant-DNA processes. Epoetin alfa is described as a 165-amino-acid erythropoiesis-stimulating glycoprotein with approximately 30,400 Da molecular weight.

Mechanism of Action

Erythropoietin binds to the erythropoietin receptor on erythroid progenitor cells. Receptor activation promotes intracellular signaling, including JAK2-mediated pathways, which support erythroid-cell survival and differentiation.

The biological activity results in:

  • Stimulation of erythroid progenitor cells
  • Increased red blood cell production
  • Promotion of erythroid-cell differentiation
  • Reduction of apoptosis in erythroid precursor cells
  • Maintenance of circulating red blood cell mass

Pharmaceutical Applications

Recombinant erythropoietin products are used as erythropoiesis-stimulating agents in specified clinical settings, including anemia associated with conditions such as:

  • Chronic kidney disease
  • Certain chemotherapy-associated anemias
  • Selected zidovudine-associated anemia
  • Certain surgical/perioperative settings

Specific indications depend on the individual epoetin product and applicable regulatory labeling.

Erythropoietin API

Erythropoietin is a biological API / recombinant therapeutic protein rather than a conventional chemically synthesized small molecule.

Important quality characteristics include:

  • Protein identity
  • Biological potency
  • Purity
  • Protein concentration
  • Glycosylation profile
  • Charge variants
  • Aggregates
  • Host-cell proteins
  • Host-cell DNA
  • Endotoxin
  • Sterility
  • Residual process-related impurities

For recombinant epoetin alfa, the reference product is a 165-amino-acid glycoprotein produced in mammalian cells using recombinant DNA technology.

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
pH (1% Solution) 2.0 – 4.0
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp